Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Mary A Bamimore"'
Autor:
Fereshteh Rostami, Mostafa Shokoohi, Mary Aderayo Bamimore, Maryam Nasirian, Mehran Asadi- Aliabadi, AliAkbar Haghdoost
Publikováno v:
علوم بهداشتی ایران, Vol 5, Iss 1, Pp 1-12 (2017)
Background and purpose: Reproductive and sexual health related problems constitute one third of health problems among women aged 15 to 44 years. Sexually transmitted infections are a significant challenge for human development. We aimed to assess the
Externí odkaz:
https://doaj.org/article/1a27181749f94b91849da39c1e8e9929
Publikováno v:
JAMA dermatology. 158(3)
There are knowledge gaps regarding the relative efficacy of 3 commonly used drugs for androgenetic alopecia (AGA), namely, minoxidil and the two 5-α reductase inhibitors dutasteride and finasteride.To examine the relative efficacy of any dose and ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbf1993baf3f9e9fe0fa0d96356f36e1
https://pubmed.ncbi.nlm.nih.gov/35107586
https://pubmed.ncbi.nlm.nih.gov/35107586
Publikováno v:
Journal of Cosmetic Dermatology. 21:108-117
BACKGROUND Microneedling is a relatively novel therapeutic modality introduced in the 1990s where small, fine needles are used to create micro punctures in the skin. It is a minimally invasive procedure used for various dermatological conditions, inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34bf6ba10c9e4056a7cd6dd3e6b3633c
https://doi.org/10.1111/jocd.14525
https://doi.org/10.1111/jocd.14525
Publikováno v:
Journal of Dermatological Treatment. 33:1896-1906
Topical minoxidil (5% foam, 5% solution, and 2% solution) is FDA-approved for androgenetic alopecia (AGA) in men and women.Mechanism of action: Minoxidil acts through multiple pathways (vasodilator...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::315ba5490ae1556c6bea01f045276056
https://doi.org/10.1080/09546634.2021.1945527
https://doi.org/10.1080/09546634.2021.1945527
Autor:
Aditya K. Gupta, Tong Wang, Shruthi Polla Ravi, Mary A. Bamimore, Vincent Piguet, Antonella Tosti
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADVREFERENCES.
Management options for moderate-to-severe alopecia areata (AA) are limited owing to a lack of safe and effective treatments suitable for long-term use. However, newer agents have the potential to induce and maintain hair regrowth in patients with a b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e98e75ccd20da9a1c685e85eb23f9e3
https://pubmed.ncbi.nlm.nih.gov/36478475
https://pubmed.ncbi.nlm.nih.gov/36478475
Autor:
Hadas Grunwald, Avner Shemer, Mary A Bamimore, Eran Galili, Ralph Daniel, Renata Farhi, Riad Kassem, Aditya K. Gupta
Publikováno v:
Pediatric Dermatology. 38:806-811
Background Tinea capitis is a common fungal infection in Israel, most commonly caused by the dermatophyte Trichophyton tonsurans. Objectives To investigate the effectiveness of oral antifungal monotherapy in producing clinical or complete cure. We al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7677899484a2bc4dc1e95f51c83411a
https://doi.org/10.1111/pde.14572
https://doi.org/10.1111/pde.14572
Publikováno v:
Pediatric Dermatology. 37:1014-1022
Various monotherapies exist for tinea capitis; however, their relative efficacies have never been determined using a statistical approach which compares treatments' efficacy simultaneously. The goal of this study was to determine the relative efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6796eac0f8291ad8f64a97fef9704bfc
https://doi.org/10.1111/pde.14353
https://doi.org/10.1111/pde.14353
Publikováno v:
Skin appendage disorders. 8(5)
Background: Recently, low-dose oral minoxidil (LDOM) has entered the landscape of therapies for androgenetic alopecia (AGA). We determined whether using LDOM is associated with improving AGA in a dose-dependent manner; secondarily, we examined whethe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef49779647984bddfdfd0d69f5ebb313
https://pubmed.ncbi.nlm.nih.gov/36161084
https://pubmed.ncbi.nlm.nih.gov/36161084
Publikováno v:
Dermatologic Therapy. 35
Androgenetic alopecia (AGA) is the most common cause of hair loss in men, often requiring medical attention. The US FDA approved topical minoxidil and oral finasteride to treat AGA. Topical minoxidil requires a long-term application to observe improv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31f62e8728d3493fea842784d44c252f
https://doi.org/10.1111/dth.15323
https://doi.org/10.1111/dth.15323
Autor:
Aditya Kumar Gupta, Mary A. Bamimore
Publikováno v:
Journal of cosmetic dermatologyREFERENCES. 21(4)
Some studies have shown that platelet-rich plasma (PRP) improves androgenetic alopecia (AGA), while others do not. We determined whether the placebo effect significantly varies between split-scalp and whole-head trials on PRP monotherapy for AGA. Our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::312b7968e0caccf4adb553833b36a075
https://pubmed.ncbi.nlm.nih.gov/35100488
https://pubmed.ncbi.nlm.nih.gov/35100488